共 249 条
[1]
Pignon JP(2009)Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 4-14
[2]
le Maitre A(2003)An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92-98
[3]
Maillard E(2007)High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 264 1475-1482
[4]
Bourhis J(1993)Cisplatin and radiotherapy in the management of locally advanced head and neck cancer Int J Radiat Oncol Biol Phys 27 465-470
[5]
Adelstein DJ(2003)Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091-2098
[6]
Li Y(2006)Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Lancet 368 843-854
[7]
Adams GL(2017)Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis Lancet Oncol 18 1221-1237
[8]
Wagner H(2003)Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 933-940
[9]
Kish JA(2010)Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial Lancet Oncol 11 553-560
[10]
Ensley JF(2008)The UK standardisation of breast radiotherapy (START) trial a of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial Lancet Oncol 9 331-341